Morepen Labs reports 24 per cent rise in net sales in half yearly results
Morepen Laboratories has reported a net sales revenue of 383.30 crore in the first half year of 2019, registering a growth of 24.2 per cent as compa13-11-2019
13-11-2019
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investors Presentation (Q2'FY20), November, 2019, based on the financial performance of the Company for the Quarter and Half-year ended 30th September, 2019.13-11-2019
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Morepen Labs catches Pharma sector uptrend in Q1 FY 2019-20. Company's Net Profit rises by a whopping 256 percent led by a significant jump in its APIs exports.13-11-2019
Morepen Laboratories Ltd - 500288 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2019
The Board of Directors of the Company, in their meeting held on Wednesday, 13th November, 2019 (commenced at 12.00 Noon and concluded at 01.45 P.M.), have, inter-alia, considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the Quarter and Half-Year ended 30th September, 2019, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.13-11-2019
MOREPEN LABORATORIES LTD. - 500288 - Outcome of Board Meeting
Please find attached outcome of Board Meeting held on 13th November, 201913-11-2019
MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding loss of Share Certificates of the Company.12-11-2019
Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding loss of Share Certificates of the Company.08-11-2019
Morepen Laboratories Ltd - 500288 - Board Meeting Intimation for Approval Of The Un-Audited Financial Results For The Quarter And Half-Year Ended 30Th September,2019
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve the Un-audited Financial Results of the Company for the quarter and half-year ended 30th September, 2019.06-11-2019
Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding Issuance of duplicate Share Certificates of the Company.01-11-2019
Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding Loss Share Certificates of the Company.24-10-2019